| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/10/2002 | CN1343695A Polypeptide-human protein 15.95 contaiing pairing box structure domain and polynucleotide for coding it |
| 04/10/2002 | CN1343694A Polypeptide-human moving-like protein 10.45 and polynucleotide for coding it |
| 04/10/2002 | CN1343693A Polypeptide-human cell signal/architecture protein 10.56 and polynucleotide for coding it |
| 04/10/2002 | CN1343692A Polypeptide-neurodevelopment associated 20.13 and polynucleotide for coding it |
| 04/10/2002 | CN1343691A Polypeptide-human tetramerized peptide duplicon 40.48 and polynucleotide for coding it |
| 04/10/2002 | CN1343690A Polypeptide-human lipoprotein prerequisite protein signal peptide 9.13 and polynucleotide for coding it |
| 04/10/2002 | CN1343687A Polypeptide-transporter 17.05 and polynucleotide for coding it |
| 04/10/2002 | CN1343686A Polypeptide-nitrogen source regulatory protein P-II-8.8 and polynucleotide for coding it |
| 04/10/2002 | CN1343684A Polypeptide-angiogenesis associated protein 95.26 and polynucleotide for coding it |
| 04/10/2002 | CN1343683A Polypeptide-human nucleotide excision repair protein 17.6 and polynucleotide for coding it |
| 04/10/2002 | CN1343682A Polypeptide-zinc finger protein 41 (ZNF 41) 58.74 and polynucleotide for coding it |
| 04/10/2002 | CN1343681A Polypeptide-cell signalling protein MyD 10.12 and polynucleotide for coding it |
| 04/10/2002 | CN1343680A Polypeptide-programmed cell death negative regulatory factor Ich-1s 12.43 and polynucleotide for coding it |
| 04/10/2002 | CN1343679A Polypeptide-human zinc finger protein 30-52.8 and polynucleotide for coding it |
| 04/10/2002 | CN1343678A Polypeptide-protein 11.77 containing bindin-dependent transport system and polynucleotide for coding it |
| 04/10/2002 | CN1343677A Polypeptide-protein 9.02 containing microtubule-associated protein domain characteristics in Tau and MAP protein and polynucleotide for coding it |
| 04/10/2002 | CN1343676A Polypeptide-infectious epithelioma virus (FPV)048 protein 13.2 and polynucleotide for coding it |
| 04/10/2002 | CN1343675A Polypeptide-cytokine receptor 11.44 and polynucleotide for coding it |
| 04/10/2002 | CN1343674A Polypeptide-cytochrome b34.32 and polynucleotide for coding it |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369204 Receptor known to be expressed in large amounts on the surface of osteoclasts and associated with bone resorption; use treating osteoporosis and/or in the inhibition of tumor cell growth |
| 04/09/2002 | US6369203 Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 04/09/2002 | US6369202 Genes encoding LSIRF polypeptides |
| 04/09/2002 | US6369201 For increasing muscle synthesis and treating disease in vertebrate subjects, for reducing myostatin activity |
| 04/09/2002 | US6369196 Molecules of the card-related protein family and uses thereof |
| 04/09/2002 | US6369045 Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy |
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368842 An isolated nucleic acid; therapy for neuroblastomas in infant brains, uterus, lung, ovary adenocarcinomas and leukocytes |
| 04/09/2002 | US6368839 Aldolase catalytic antibody |
| 04/09/2002 | US6368829 An isolated nucleic acid encoding a polypeptide for a tumor suppressor gene; diagnosis and therapy for diseases |
| 04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 04/09/2002 | US6368814 Tricyclic antidepressants and metabolites thereof |
| 04/09/2002 | US6368812 Exposing transfected cells with dna or infected rna encoding a galanin receptor and a chemical that is a possible receptor activator; measure the receptor activity in the absence and presence of the chemical with the transfected cells |
| 04/09/2002 | US6368792 A polynucleotide; monitoring, diagnosing, preventing and treating diseases, tumors or metastases of the gastrointestinal tract |
| 04/09/2002 | US6368601 Isolated dna |
| 04/09/2002 | US6368597 Methods of treating diabetes |
| 04/09/2002 | US6368596 Monoclonal antibody complex; anticancer agent |
| 04/09/2002 | CA2128407C Synthetic peptides for a rubella vaccine |
| 04/09/2002 | CA2009306C Expression systems for amidating enzyme |
| 04/09/2002 | CA1341356C Transkaryotic implantation |
| 04/09/2002 | CA1341355C Production and use of il-6 |
| 04/06/2002 | CA2358239A1 Novel siglec-like gene |
| 04/06/2002 | CA2358235A1 Novel siglec gene |
| 04/04/2002 | WO2002027323A1 Novel antibody, immunoassay and method for prostate cancer detection |
| 04/04/2002 | WO2002027322A2 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 04/04/2002 | WO2002027019A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 04/04/2002 | WO2002027017A2 Method for quantifying phosphokinase activity on proteins |
| 04/04/2002 | WO2002026998A2 Hydrolases |
| 04/04/2002 | WO2002026997A2 Dsp-16 dual-specificity phosphatase |
| 04/04/2002 | WO2002026988A2 Human drug metabolizing enzymes |
| 04/04/2002 | WO2002026983A2 56115, a novel human twik potassium channel and uses therefor |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026963A1 Shingolipid ceramide deacylase gene |
| 04/04/2002 | WO2002026951A2 Oxidoreductases |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | WO2002026833A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/04/2002 | WO2002026832A1 Antibodies for human cytochrome p450 2d6 |
| 04/04/2002 | WO2002026831A1 Monoclonal antibody against human cathepsin w |
| 04/04/2002 | WO2002026830A1 Method for producing human anti-thymocyte immunoglobulins |
| 04/04/2002 | WO2002026829A1 Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
| 04/04/2002 | WO2002026815A2 Identification of neuroblastoma tumor suppressor genes |
| 04/04/2002 | WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026779A2 A fibrin/fibrinogen-binding conjugate |
| 04/04/2002 | WO2002026259A1 A pharmaceutical composition for treating acids and its preparation |
| 04/04/2002 | WO2002026257A1 Antibodies to the propeptide of candida albicans and methods of use |
| 04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
| 04/04/2002 | WO2002026250A2 Vaccines for proliferative ileitis |
| 04/04/2002 | WO2002026249A2 Methods for inhibition of viral infection |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002004636A8 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085921A3 Human serine-threonine kinase-4 |
| 04/04/2002 | WO2001085796A3 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 04/04/2002 | WO2001085784A3 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 04/04/2002 | WO2001085209A3 Treating t-cell mediated diseases by modulating dr6 activity |
| 04/04/2002 | WO2001081421A3 Synthetic peptides that bind to the hepatitis b virus core and e antigens |
| 04/04/2002 | WO2001080904A3 Means for diagnosing and treating carcinomas |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001072781A3 Human genes and expression products |
| 04/04/2002 | WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 04/04/2002 | WO2001066741A3 Kcnb: a novel potassium channel protein |
| 04/04/2002 | WO2001064896A3 Human enzyme molecules |
| 04/04/2002 | WO2001062792A3 Cancer treatment and prognosis involving hes-1 protein |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | WO2001053354A3 Methods for treating tumors using a fusion protein comprising il-2- polypeptides and p185-specific binding molecules |
| 04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |